| Ali Alhousseini, MD | |
|
18181 Oakwood Blvd Ste 306, Dearborn, MI 48124-3998 | |
| (313) 593-7521 | |
| Not Available |
| Full Name | Ali Alhousseini |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 21 Years |
| Location | 18181 Oakwood Blvd Ste 306, Dearborn, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124225248 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | N7201 (Texas) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 4301107334 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaumont Medical Group- Specialty Services | 7214299866 | 787 |
News Archive
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, today announced receipt of notification of the granting of a European patent with broad claims directed to compositions containing DA-DKP, a cyclic dipeptide diketopiperazine which is the active ingredient of Ampion™.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Henry Ford Health System is embarking on a major initiative over the coming year to inform its patients about "The Conversation" - an often daunting and uncomfortable discussion of advance planning for death and dying.
The Wall Street Journal: "Almost 2,000 employers and unions will be eligible to submit retirees' medical bills for reimbursement by a $5 billion federal fund, the Obama administration will disclose Tuesday, suggesting the fund will be spread widely but thinly." General Motors, Pepsi, Alcoa and Pfizer are among the major employers that are said to be signing up.
What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) provides recommendations on screening and advice for primary care physicians to deal with this specific population's health care needs.
› Verified 6 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831139088 PECOS PAC ID: 6709799166 Enrollment ID: O20040102000790 |
News Archive
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, today announced receipt of notification of the granting of a European patent with broad claims directed to compositions containing DA-DKP, a cyclic dipeptide diketopiperazine which is the active ingredient of Ampion™.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Henry Ford Health System is embarking on a major initiative over the coming year to inform its patients about "The Conversation" - an often daunting and uncomfortable discussion of advance planning for death and dying.
The Wall Street Journal: "Almost 2,000 employers and unions will be eligible to submit retirees' medical bills for reimbursement by a $5 billion federal fund, the Obama administration will disclose Tuesday, suggesting the fund will be spread widely but thinly." General Motors, Pepsi, Alcoa and Pfizer are among the major employers that are said to be signing up.
What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) provides recommendations on screening and advice for primary care physicians to deal with this specific population's health care needs.
› Verified 6 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366498107 PECOS PAC ID: 6709799166 Enrollment ID: O20040311001138 |
News Archive
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, today announced receipt of notification of the granting of a European patent with broad claims directed to compositions containing DA-DKP, a cyclic dipeptide diketopiperazine which is the active ingredient of Ampion™.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Henry Ford Health System is embarking on a major initiative over the coming year to inform its patients about "The Conversation" - an often daunting and uncomfortable discussion of advance planning for death and dying.
The Wall Street Journal: "Almost 2,000 employers and unions will be eligible to submit retirees' medical bills for reimbursement by a $5 billion federal fund, the Obama administration will disclose Tuesday, suggesting the fund will be spread widely but thinly." General Motors, Pepsi, Alcoa and Pfizer are among the major employers that are said to be signing up.
What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) provides recommendations on screening and advice for primary care physicians to deal with this specific population's health care needs.
› Verified 6 days ago
| Entity Name | Beaumont Medical Group Hospital Based Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427567858 PECOS PAC ID: 3072875889 Enrollment ID: O20180314001796 |
News Archive
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, today announced receipt of notification of the granting of a European patent with broad claims directed to compositions containing DA-DKP, a cyclic dipeptide diketopiperazine which is the active ingredient of Ampion™.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Henry Ford Health System is embarking on a major initiative over the coming year to inform its patients about "The Conversation" - an often daunting and uncomfortable discussion of advance planning for death and dying.
The Wall Street Journal: "Almost 2,000 employers and unions will be eligible to submit retirees' medical bills for reimbursement by a $5 billion federal fund, the Obama administration will disclose Tuesday, suggesting the fund will be spread widely but thinly." General Motors, Pepsi, Alcoa and Pfizer are among the major employers that are said to be signing up.
What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) provides recommendations on screening and advice for primary care physicians to deal with this specific population's health care needs.
› Verified 6 days ago
| Entity Name | Beaumont Medical Group- Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, today announced receipt of notification of the granting of a European patent with broad claims directed to compositions containing DA-DKP, a cyclic dipeptide diketopiperazine which is the active ingredient of Ampion™.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Henry Ford Health System is embarking on a major initiative over the coming year to inform its patients about "The Conversation" - an often daunting and uncomfortable discussion of advance planning for death and dying.
The Wall Street Journal: "Almost 2,000 employers and unions will be eligible to submit retirees' medical bills for reimbursement by a $5 billion federal fund, the Obama administration will disclose Tuesday, suggesting the fund will be spread widely but thinly." General Motors, Pepsi, Alcoa and Pfizer are among the major employers that are said to be signing up.
What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) provides recommendations on screening and advice for primary care physicians to deal with this specific population's health care needs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ali Alhousseini, MD 26901 Beaumont Blvd Ste 3d, Southfield, MI 48033-3849 Ph: () - | Ali Alhousseini, MD 18181 Oakwood Blvd Ste 306, Dearborn, MI 48124-3998 Ph: (313) 593-7521 |
News Archive
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, today announced receipt of notification of the granting of a European patent with broad claims directed to compositions containing DA-DKP, a cyclic dipeptide diketopiperazine which is the active ingredient of Ampion™.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Henry Ford Health System is embarking on a major initiative over the coming year to inform its patients about "The Conversation" - an often daunting and uncomfortable discussion of advance planning for death and dying.
The Wall Street Journal: "Almost 2,000 employers and unions will be eligible to submit retirees' medical bills for reimbursement by a $5 billion federal fund, the Obama administration will disclose Tuesday, suggesting the fund will be spread widely but thinly." General Motors, Pepsi, Alcoa and Pfizer are among the major employers that are said to be signing up.
What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) provides recommendations on screening and advice for primary care physicians to deal with this specific population's health care needs.
› Verified 6 days ago
Peter Stevenson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2100 Monre, Dearborn, MI 48124 Phone: 313-278-3900 | |
Maria F Hayes, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 18181 Oakwood Blvd, Ste 109, Dearborn, MI 48124 Phone: 313-299-6650 Fax: 313-299-6651 | |
David M Magyar, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 18181 Oakwood Blvd, Ste 109, Dearborn, MI 48124 Phone: 313-299-6650 Fax: 313-299-6651 | |
Heba Al Butairi, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 18101 Oakwood Blvd, Ob.gyn Medical Education, Dearborn, MI 48124 Phone: 313-436-2582 | |
Dr. Evan Charles Delancey, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 870-549-2207 | |
Dr. Rusna K Jhita, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-436-2577 Fax: 313-436-2756 | |
Todd Allen, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Suite 200, Dearborn, MI 48124 Phone: 313-593-5810 |